What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
His primary areas of study are Breast cancer, Internal medicine, Oncology, Pathology and Cancer.
His Breast cancer study combines topics in areas such as Clinical trial and Surgery.
His research in Surgery intersects with topics in Sentinel lymph node, Mastectomy, Lymph node and Hazard ratio.
His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology and Gynecology.
His work carried out in the field of Oncology brings together such families of science as Trastuzumab, MammaPrint, Ductal carcinoma, Estrogen receptor and Disease.
His Cancer research includes elements of Cancer research and Predictive value of tests.
His most cited work include:
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (2934 citations)
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update (1998 citations)
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 (1828 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Breast cancer, Internal medicine, Oncology, Pathology and Cancer.
The concepts of his Breast cancer study are interwoven with issues in Biopsy, Gynecology, Surgery and Disease.
His Surgery research is multidisciplinary, incorporating elements of Mastectomy, Metastasis, Sentinel node and Axilla.
His biological study spans a wide range of topics, including Clinical trial, Trastuzumab, Proportional hazards model, Triple-negative breast cancer and Adjuvant therapy.
His Pathology research integrates issues from Breast carcinoma and Adenocarcinoma.
His Cancer study incorporates themes from Gastroenterology and Cancer research.
He most often published in these fields:
- Breast cancer (76.85%)
- Internal medicine (71.49%)
- Oncology (60.88%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (71.49%)
- Breast cancer (76.85%)
- Oncology (60.88%)
In recent papers he was focusing on the following fields of study:
Giuseppe Viale mostly deals with Internal medicine, Breast cancer, Oncology, Hazard ratio and Clinical trial.
His Breast cancer research is multidisciplinary, relying on both Clinical endpoint and Confidence interval.
His Oncology research incorporates elements of MEDLINE, Tamoxifen, Disease, Triple-negative breast cancer and Cohort.
His Hazard ratio research is multidisciplinary, incorporating perspectives in Proportional hazards model, Mastectomy, MammaPrint and Adjuvant therapy.
The study incorporates disciplines such as Cancer research and Immune system in addition to Cancer.
His Surgery research includes elements of Sentinel node and Axilla.
Between 2017 and 2021, his most popular works were:
- De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. (494 citations)
- Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials (293 citations)
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. (270 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His primary areas of investigation include Breast cancer, Internal medicine, Oncology, Hazard ratio and Clinical trial.
His work deals with themes such as Immunohistochemistry, MEDLINE, Confidence interval, Clinical endpoint and Proportional hazards model, which intersect with Breast cancer.
His Oncology research is multidisciplinary, incorporating perspectives in Trastuzumab, Guideline, Tamoxifen, Estrogen receptor and Estrogen.
Giuseppe Viale studied Estrogen receptor and Carcinoma that intersect with Statistical significance, Univariate analysis, Lymph node and Retrospective cohort study.
His studies in Hazard ratio integrate themes in fields like Predictive value of tests, Chemotherapy regimen, MammaPrint and Anastrozole.
His work carried out in the field of Surgery brings together such families of science as Mastectomy, Sentinel node and Axilla.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
